Related references
Note: Only part of the references are listed.Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108)
Seema A. Khan et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-Center, Prospective Registry Study
Atilla Soran et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Primary Surgery with Systemic Therapy in Patients with de Novo Stage IV Breast Cancer: 10-year Follow-up; Protocol MF07-01 Randomized Clinical Trial
Atilla Soran et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2021)
Oligometastatic Breast Cancer: How to Manage It?
Vittoria Barberi et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model
Anouk E. J. Latenstein et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract
Giuseppe Rosiello et al.
JOURNAL OF SURGICAL ONCOLOGY (2020)
Adjuvant chemotherapy for patients with gastric neuroendocrine carcinomas or mixed adenoneuroendocrine carcinomas
J. -P. Lin et al.
BRITISH JOURNAL OF SURGERY (2020)
Novel prognostic nomograms for female patients with breast cancer and bone metastasis at presentation
Zhan Wang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Novel HER2-targeted therapies for HER2-positive metastatic breast cancer
Siddharth Kunte et al.
CANCER (2020)
Development of an Individualized Prediction Calculator for the Benefit of Postoperative Radiotherapy in Patients with Surgically Resected De Novo Stage IV Breast Cancer
Byoung Hyuck Kim et al.
CANCERS (2020)
Conditional survival analysis of hepatocellular carcinoma
Mihir M. Shah et al.
JOURNAL OF SURGICAL ONCOLOGY (2020)
Aggressive Local Treatment Improves Survival in Stage IV Breast Cancer With Synchronous Metastasis
Chen-Lu Lian et al.
FRONTIERS IN ONCOLOGY (2020)
Conditional Survival of female patients with operable invasive Breast Cancer in US: A population-based study
Bolun Ai et al.
JOURNAL OF CANCER (2020)
Why Has Breast Cancer Screening Failed to Decrease the Incidence of de Novo Stage IV Disease?
Danielle R. Heller et al.
CANCERS (2019)
Survival benefit of radiotherapy after surgery in de novo stage IV breast cancer: a population-based propensity-score matched analysis
Yi-Jun Kim et al.
SCIENTIFIC REPORTS (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01
Atilla Soran et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Conditional Survival of Patients With Gastric Cancer Who Undergo Curative Resection: A Multi-Institutional Analysis in China
Pengliang Wang et al.
CANCER (2018)
Prognostic impact of metastatic pattern in stage IV breast cancer at initial diagnosis
Bernardo Amadeo Leone et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial
Veronique Dieras et al.
LANCET ONCOLOGY (2017)
Development and validation of a nomogram predicting the overall survival of stage IV breast cancer patients
Shunrong Li et al.
CANCER MEDICINE (2017)
Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Nicholas J. Short et al.
BLOOD (2016)
Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial
Rajendra Badwe et al.
LANCET ONCOLOGY (2015)
Conditional Disease-Free Survival After Surgical Resection of Gastrointestinal Stromal Tumors A Multi-institutional Analysis of 502 Patients
Danielle A. Bischof et al.
JAMA SURGERY (2015)
Can Locoregional Treatment of the Primary Tumor Improve Outcomes for Women With Stage IV Breast Cancer at Diagnosis?
David H. A. Nguyen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
The impact of new chemotherapeutic and agents on survival in a population-based of women with metastatic breast cancer hormone cohort
Stephen K. Chia et al.
CANCER (2007)
Share Paper
